Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Hoepner

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
Journal of the Neurological Sciences|March 6, 2016
Basal ganglia alterations appearing in transcranial sonography prior to MRI in a patient with Creutzfeld-Jacob DiseaseThomas Grüter, Katrin Strassburger-Krogias, Robert Hoepner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2013
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patientsStefanie Dahlhaus, Robert Hoepner, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders|January 11, 2014
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathyRobert Hoepner, Stefanie Dahlhaus, Susanne Kollar, et al.
Praxis|May 21, 2021
[The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection]Manuela Funke-Chambour, Laurence Feldmeyer, Robert Hoepner, et al.
Cells|September 28, 2023
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor SignalingMaud Bagnoud, Jana Remlinger, Marine Massy, et al.
Therapeutic Advances in Neurological Disorders|May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient ageMyriam Briner, Maud Bagnoud, Andrei Miclea, et al.
European Journal of Neurology|October 21, 2020
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathyMarkus Kinner, Christian Prehn, Ruth Schneider, et al.
Journal of Neurology|October 23, 2012
Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopiesRobert Hoepner, Kirsten Labudda, Theodor W May, et al.
Therapeutic Advances in Neurological Disorders|January 15, 2021
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational studyLara Diem, Maxine Bürge, Alexander Leichtle, et al.
Therapeutic Advances in Neurological Disorders|August 5, 2021
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective studyPanagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
Journal of the Neurological Sciences|March 6, 2016
Basal ganglia alterations appearing in transcranial sonography prior to MRI in a patient with Creutzfeld-Jacob DiseaseThomas Grüter, Katrin Strassburger-Krogias, Robert Hoepner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 23, 2013
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patientsStefanie Dahlhaus, Robert Hoepner, Andrew Chan, et al.
Therapeutic Advances in Neurological Disorders|January 11, 2014
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathyRobert Hoepner, Stefanie Dahlhaus, Susanne Kollar, et al.
Praxis|May 21, 2021
[The Long-COVID Syndrome - a New Clinical Picture after COVID-19 Infection]Manuela Funke-Chambour, Laurence Feldmeyer, Robert Hoepner, et al.
Cells|September 28, 2023
In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor SignalingMaud Bagnoud, Jana Remlinger, Marine Massy, et al.
Therapeutic Advances in Neurological Disorders|May 21, 2019
Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient ageMyriam Briner, Maud Bagnoud, Andrei Miclea, et al.
European Journal of Neurology|October 21, 2020
Course of neuropsychological impairment during natalizumab-associated progressive multifocal leukoencephalopathyMarkus Kinner, Christian Prehn, Ruth Schneider, et al.
Journal of Neurology|October 23, 2012
Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopiesRobert Hoepner, Kirsten Labudda, Theodor W May, et al.
Therapeutic Advances in Neurological Disorders|January 15, 2021
Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational studyLara Diem, Maxine Bürge, Alexander Leichtle, et al.
Therapeutic Advances in Neurological Disorders|August 5, 2021
Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective studyPanagiotis Chaloulos-Iakovidis, Franca Wagner, Lea Weber, et al.
Pageof 13